Open Access Open Access  Restricted Access Subscription or Fee Access

What do we need to be telling our patients about opioids together with acetaminophen?

Robert Hutchison, PharmD, BCACP

Keywords


opioids, acetaminophen, patients

Full Text:

PDF

References


IMS Institute for Healthcare Informatics: Institute_Documents_IHII_UseOfMed_report. Available at www.imshealth.com_imshealth_Global_Content_IMS. Accessed January 28, 2014.

Singla A, Sloan P: Pharmacokinetic evaluation of hydrocodone/acetaminophen for pain management. J Opioid Manag. 2013; 9(1): 71-80.

Larson AM, Polson J, Fontana RJ, et al.: Acute Liver Failure Study Group (ALFSG). Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective study. Hepatology. 2005; 42: 1364-1372.

Bower WA, Johns M, Margolis HS, et al.: Population-based surveillance for acute liver failure. Am J Gastroenterol. 2007; 102: 2459-2463.

Nourjah P, Ahmad SR, Karwoski C, et al.: Estimates of acetaminophen (Paracetamol)-associated overdoses in the United States. Pharmacoepidemiol Drug Saf. 2006; 15: 398-405.

Lai MW, Klein-Schwartz W, Rodgers GC, et al.: 2005 Annual Report of the American Association of Poison Control Centers’ national poisoning and exposure database. Clin Toxicol. 2006; 44: 803-932.

US Food and Drug Administration: Available at http://www.fda.gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ucm381650.htm. Accessed January 28, 2014.




DOI: https://doi.org/10.5055/jom.2014.0196

Refbacks

  • There are currently no refbacks.